| Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information. |
| |
| Device | HER2 CISH PHARMDX KIT |
| Generic Name | Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer |
| Regulation Number | 864.1890 |
| Applicant | Dako Denmark A/S 42 Produktionsvej Dk-2600 Glostrup DK-2600 |
| PMA Number | P100024 |
| Supplement Number | S008 |
| Date Received | 01/08/2016 |
| Decision Date | 01/29/2016 |
| Withdrawal Date | 01/24/2018 |
| Product Code |
NYQ |
| Advisory Committee |
Pathology |
| Supplement Type | 30-Day Notice |
| Supplement Reason | Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
Approval Order Statement CHANGE OF THE IN-PROCESS QC "METAPHASE FISH TEST', WITH CHANGE NUMBER R02285. PMA APPROVED DEVICES AFFECTED BY THE CHANGE ARE: HER2 CISH PHARMDX KIT AND HER2 IQFISH PHARMDX. |
|
|